Shi‐Shan Mao

1.0k total citations
18 papers, 617 citations indexed

About

Shi‐Shan Mao is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Shi‐Shan Mao has authored 18 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Hematology. Recurrent topics in Shi‐Shan Mao's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Peptidase Inhibition and Analysis (6 papers) and Protease and Inhibitor Mechanisms (3 papers). Shi‐Shan Mao is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Peptidase Inhibition and Analysis (6 papers) and Protease and Inhibitor Mechanisms (3 papers). Shi‐Shan Mao collaborates with scholars based in United States and Taiwan. Shi‐Shan Mao's co-authors include Stephen J. Gardell, Jules A. Shafer, Carolyn M. Cooper, Steven S. Carroll, Theresa Wood, Dennis Colussi, Joseph P. Vacca, Christine Burlein, Jia-Tsrong Jan and Ying‐Ta Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Shi‐Shan Mao

18 papers receiving 581 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shi‐Shan Mao 211 192 104 99 76 18 617
Kyle Elrod 269 1.3× 145 0.8× 110 1.1× 28 0.3× 62 0.8× 23 606
Roopa Rai 119 0.6× 113 0.6× 74 0.7× 41 0.4× 19 0.3× 21 360
Stanley L. Gaul 239 1.1× 116 0.6× 213 2.0× 242 2.4× 31 0.4× 24 871
Sadayappan V. Rahavendran 170 0.8× 25 0.1× 89 0.9× 102 1.0× 74 1.0× 18 506
Francesco Turrini 376 1.8× 153 0.8× 40 0.4× 45 0.5× 94 1.2× 56 1.3k
Gaëlle Noé 244 1.2× 55 0.3× 43 0.4× 46 0.5× 192 2.5× 26 615
Amit Shah 256 1.2× 150 0.8× 63 0.6× 40 0.4× 8 0.1× 29 538
Anton Cheltsov 338 1.6× 24 0.1× 121 1.2× 42 0.4× 105 1.4× 19 640
R.M. Bandaranayake 259 1.2× 66 0.3× 33 0.3× 222 2.2× 112 1.5× 10 570
Federico Falchi 669 3.2× 60 0.3× 302 2.9× 74 0.7× 143 1.9× 47 1.2k

Countries citing papers authored by Shi‐Shan Mao

Since Specialization
Citations

This map shows the geographic impact of Shi‐Shan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Shan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Shan Mao more than expected).

Fields of papers citing papers by Shi‐Shan Mao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi‐Shan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Shan Mao. The network helps show where Shi‐Shan Mao may publish in the future.

Co-authorship network of co-authors of Shi‐Shan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Shan Mao. A scholar is included among the top collaborators of Shi‐Shan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Shan Mao. Shi‐Shan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jan, Jia-Tsrong, Ting-Jen Rachel Cheng, Yu-Pu Juang, et al.. (2021). Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 118(5). 130 indexed citations
2.
Liverton, Nigel J., M. Katharine Holloway, John A. McCauley, et al.. (2008). Molecular Modeling Based Approach to Potent P2−P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease. Journal of the American Chemical Society. 130(14). 4607–4609. 77 indexed citations
3.
Mao, Shi‐Shan, Jillian DiMuzio, Carolyn McHale, et al.. (2007). A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3–4A protease at low enzyme concentrations. Analytical Biochemistry. 373(1). 1–8. 23 indexed citations
4.
Mao, Shi‐Shan, Marie A. Holahan, Guoxin Wu, et al.. (2005). Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice. Blood Coagulation & Fibrinolysis. 16(6). 407–415. 30 indexed citations
5.
Nantermet, Philippe G., James C. Barrow, Stacey R. Lindsley, et al.. (2004). Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P 1 ′ group. Bioorganic & Medicinal Chemistry Letters. 14(9). 2141–2145. 48 indexed citations
6.
Mao, Shi‐Shan, Dennis Colussi, Michele Bosserman, et al.. (2003). Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor. Analytical Biochemistry. 319(1). 159–170. 27 indexed citations
7.
Ferrer, Marc, Paul Zuck, Shi‐Shan Mao, et al.. (2003). Miniaturizable homogenous time-resolved fluorescence assay for carboxypeptidase B activity. Analytical Biochemistry. 317(1). 94–98. 13 indexed citations
8.
Barrow, James C., Philippe G. Nantermet, Shaun R. Stauffer, et al.. (2003). Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics. Journal of Medicinal Chemistry. 46(25). 5294–5297. 36 indexed citations
9.
Mao, Shi‐Shan, Carolyn M. Cooper, Theresa Wood, Jules A. Shafer, & Stephen J. Gardell. (1999). Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B. Journal of Biological Chemistry. 274(49). 35046–35052. 105 indexed citations
10.
Cook, James C., Loren D. Schultz, Jin Huang, et al.. (1998). Expression and Purification of Recombinant Tick Anticoagulant Peptide (Y1W/D10R) Double Mutant Secreted bySaccharomyces cerevisiae. Protein Expression and Purification. 13(3). 291–300. 2 indexed citations
11.
Lewis, Sidney D., Bobby J. Lucas, Stephen F. Brady, et al.. (1998). Characterization of the Two-step Pathway for Inhibition of Thrombin by α-Ketoamide Transition State Analogs. Journal of Biological Chemistry. 273(9). 4843–4854. 9 indexed citations
12.
Mao, Shi‐Shan, Craig T. Przysiecki, Julie A. Krueger, et al.. (1998). Selective Inhibition of Factor Xa in the Prothrombinase Complex by the Carboxyl-terminal Domain of Antistasin. Journal of Biological Chemistry. 273(46). 30086–30091. 7 indexed citations
13.
Feng, Dong-Mei, Stephen J. Gardell, Sidney D. Lewis, et al.. (1997). Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position. Journal of Medicinal Chemistry. 40(23). 3726–3733. 53 indexed citations
14.
Mao, Shi‐Shan, et al.. (1995). Identification and Characterization of Variants of Tick Anticoagulant Peptide with Increased Inhibitory Potency toward Human Factor Xa. Biochemistry. 34(15). 5098–5103. 16 indexed citations
15.
Lyle, Elizabeth A., Michael J. Mellott, Stephen F. Brady, et al.. (1995). Inhibition of Thrombin by Peptides Containing Lysyl-α-Keto Carbonyl Derivatives. Thrombosis and Haemostasis. 74(4). 1107–1112. 23 indexed citations
16.
Mao, Shi‐Shan. (1994). Factor Xa inhibitors. Perspectives in Drug Discovery and Design. 1(3). 423–430. 8 indexed citations
17.
Townsend, Craig A. & Shi‐Shan Mao. (1987). Clavulanic acid biosynthesis: the stereochemical course of β-lactam formation from chiral glycerol. Journal of the Chemical Society Chemical Communications. 86–89. 7 indexed citations
18.
Townsend, Craig A., Mengfei Ho, & Shi‐Shan Mao. (1986). The stereochemical fate of (2RS,5R)- and (2RS,5S)-[5-3H]ornithine in clavulanic acid biosynthesis. Journal of the Chemical Society Chemical Communications. 638–638. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyle Elrod Breakdown of academic impact, for papers by Roopa Rai Breakdown of academic impact, for papers by Stanley L. Gaul Breakdown of academic impact, for papers by Sadayappan V. Rahavendran Breakdown of academic impact, for papers by Francesco Turrini Breakdown of academic impact, for papers by Gaëlle Noé Breakdown of academic impact, for papers by Amit Shah Breakdown of academic impact, for papers by Anton Cheltsov Breakdown of academic impact, for papers by R.M. Bandaranayake Breakdown of academic impact, for papers by Federico Falchi
Rankless by CCL
2026